Nonpayment for preventable infections in U.S. hospitals.
Nonpayment for preventable infections in U.S. hospitals.
复制标题
美国医院不支付可预防感染的费用。
DOI:
10.1056/nejmc1213732
复制
发表时间:
2013
期刊:
影响因子:
--
通讯作者:
Jha,AshishK
中科院分区:
文献类型:
--
作者:
Lee,GraceM;Soumerai,StephenB;Jha,AshishK
To the Editor: Lee et al.(Oct. 11 issue) 1 found that the penalty imposed by the Centers for Medicare and Medicaid Services (CMS) of nonpayment for health care–acquired conditions did not result in a significant lowering of infection rates. This finding furthers the evidence that line-item penalties applied to a predominantly bundled payment system result in little change in quality. Medicare uses a diagnosis-related group (DRG) payment system, which for most DRGs allows an increase in reimbursement if a “comorbidity” or “major comorbidity” diagnosis exists. However, maximum reimbursement can still often be achieved even in the face of a health care–acquired condition by billing with the use of codes for a different coexisting diagnosis. During the first year after implementation of the CMS policy of nonpayment for health care–acquired conditions, only $18.8 million was recouped from hospitals nationwide; of this amount, only $85,254 was for vascular catheter-associated infections. 2 The Commonwealth Fund has also reported that this initiative did not produce a major change in care practices in safety-net hospitals. 3 For valuebased purchasing initiatives to improve quality, not only must meaningful metrics be used, but also considerable financial penalties and rewards must exist. 4